← Leaderboards
Tatyana V. Golovkina
Jackson Laboratory
$20,197,921
Attributed
$21,613,854
Total exposure
16
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,613,854 · 16
By mechanism
R01$18,244,028 · 9
R21$2,165,515 · 5
R56$1,204,311 · 2
Top collaborators
- Michael Andrew Fischbach5 shared
- Dominique M Missiakas2 shared
Others in their field
Top investigators on “Retroviridae”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- John M Coffin · Miriam Hospital$18,400,250
- Ellis L Reinherz · Dana-Farber Cancer Institute$16,769,846
- John M. Sedivy · Brown University$12,925,113
- Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences$11,669,600
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$10,916,471
Research focus
RetroviridaeGenesResistanceMediatingResponseImmune ResponseVirusMurine Leukemia VirusMouse Mammary Tumor VirusInfectionNeutralizing AntibodyPredispositionViralPathogenProductionGeneticMapsImmunityAntibodiesPathway InteractionsImmune SystemAnimalsCellsVaccines
Grant awards (57)
Retroviral infection and new modulators of the MHCII pathway$793,725
R01 · FY2025 · AI · contact PI
Virally-induced tumorigenesis controlled by the microbiota$534,676
R01 · FY2025 · CA · contact PI
Manipulation of antibody responses by a retrovirus$451,000
R21 · FY2025 · AI · contact PI
Host-driven antibody responses against Staphylococcus aureus$205,000
R21 · FY2025 · AI · contact PI
Retroviral infection and new modulators of the MHCII pathway$799,185
R01 · FY2024 · AI · contact PI
Host-driven antibody responses against Staphylococcus aureus$246,000
R21 · FY2024 · AI · contact PI
Identification of the gene controlling murine retrovirus in YBR mice$205,000
R21 · FY2024 · AI · contact PI
Virally-induced tumorigenesis controlled by the microbiota$467,351
R01 · FY2023 · CA · contact PI
Identification of the gene controlling murine retrovirus in YBR mice$246,000
R21 · FY2023 · AI · contact PI
Virally-induced tumorigenesis controlled by the microbiota$467,351
R01 · FY2022 · CA · contact PI
A neonatal mouse model to study retrovirus-specific humoral responses$463,156
R01 · FY2022 · AI · contact PI
New retroviral restriction factor$776,245
R56 · FY2021 · AI · contact PI
Virally-induced tumorigenesis controlled by the microbiota$476,888
R01 · FY2021 · CA · contact PI
A neonatal mouse model to study retrovirus-specific humoral responses$463,156
R01 · FY2021 · AI · contact PI
New retroviral restriction factor$644,871
R01 · FY2020 · AI · contact PI
A neonatal mouse model to study retrovirus-specific humoral responses$539,821
R01 · FY2020 · AI · contact PI
Virally-induced tumorigenesis controlled by the microbiota$476,888
R01 · FY2020 · CA · contact PI
New retroviral restriction factor$641,742
R01 · FY2019 · AI · contact PI
Virally-induced tumorigenesis controlled by the microbiota$492,388
R01 · FY2019 · CA · contact PI
A neonatal mouse model to study retrovirus-specific humoral responses$463,156
R01 · FY2019 · AI · contact PI
A neonatal mouse model to study retrovirus-specific humoral responses$78,771
R01 · FY2019 · AI · contact PI
New retroviral restriction factor$637,751
R01 · FY2018 · AI · contact PI
A neonatal mouse model to study retrovirus-specific humoral responses$463,156
R01 · FY2018 · AI · contact PI
New retroviral restriction factor$634,167
R01 · FY2017 · AI · contact PI
Genetic Basis for Sensitivity of Neonates to Retroviruses$197,500
R21 · FY2017 · AI · contact PI
New retroviral restriction factor$659,848
R01 · FY2016 · AI · contact PI
Retroviral Evasion of Immune Response$423,783
R01 · FY2016 · AI · contact PI
Genetic Basis for Sensitivity of Neonates to Retroviruses$237,000
R21 · FY2016 · AI · contact PI
Leukemia-promoting effects of microbiota$171,825
R21 · FY2016 · CA · contact PI
Retroviral Evasion of Immune Response$423,783
R01 · FY2015 · AI · contact PI
Leukemia-promoting effects of microbiota$206,190
R21 · FY2015 · CA · contact PI
Retroviral Evasion of Immune Response$423,783
R01 · FY2014 · AI · contact PI
Retroviral Evasion of Immune Response$398,357
R01 · FY2013 · AI · contact PI
Retroviral Evasion of Immune Response$432,127
R01 · FY2012 · AI · contact PI
Cloning of the vic1 gene, a novel retrovirus restriction factor$347,457
R01 · FY2012 · CA · contact PI
Cloning of the vic1 gene, a novel retrovirus restriction factor$347,457
R01 · FY2011 · CA · contact PI
Retroviral evasion of immune response$428,066
R56 · FY2010 · AI · contact PI
Cloning of the vic1 gene, a novel retrovirus restriction factor$358,202
R01 · FY2010 · CA · contact PI
Cloning of the vic1 gene, a novel retrovirus restriction factor$351,175
R01 · FY2009 · CA · contact PI
Novel pathways in Retroviral Tumorigenesis$265,424
R01 · FY2009 · CA · contact PI
Cloning of the vic1 gene, a novel retrovirus restriction factor$316,675
R01 · FY2008 · CA · contact PI
Novel pathways in Retroviral Tumorigenesis$265,351
R01 · FY2008 · CA · contact PI
Mechanism of Resistance to MMTV Induced Mammary Tumors$20,000
R01 · FY2008 · CA · contact PI
Subversion of Innate Immune Response by Retroviruses$323,839
R01 · FY2007 · CA · contact PI
Novel pathways in Retroviral Tumorigenesis$264,562
R01 · FY2007 · CA · contact PI
Mechanism of Resistance to MMTV Induced Mammary Tumors$36,820
R01 · FY2007 · CA · contact PI
Subversion of Innate Immune Response by Retroviruses$332,968
R01 · FY2006 · CA · contact PI
Novel pathways in Retroviral Tumorigenesis$272,463
R01 · FY2006 · CA · contact PI
Subversion of Innate Immune Response by Retroviruses$362,675
R01 · FY2005 · CA
Mechanism of Resistance to MMTV Induced Mammary Tumors$144,005
R01 · FY2005 · CA
Mechanism of Resistance to MMTV Induced Mammary Tumors$126,575
R01 · FY2005 · CA
Subversion of Innate Immune Response by Retroviruses$362,675
R01 · FY2004 · CA
Mechanism of Resistance to MMTV Induced Mammary Tumors$270,580
R01 · FY2004 · CA
Subversion of Innate Immune Response by Retroviruses$362,675
R01 · FY2003 · CA
Mechanism of Resistance to MMTV Induced Mammary Tumors$270,580
R01 · FY2003 · CA
Mechanism of Resistance to MMTV Induced Mammary Tumors$270,580
R01 · FY2002 · CA
Mechanism of Resistance to MMTV Induced Mammary Tumors$271,410
R01 · FY2001 · CA